Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

For cervical cancer patients in Saskatchewan, the new Interstitial High-Dose-Rate (HDR) Gynecological Brachytherapy program ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher ...

A 58-year-old woman mistook her womb cancer symptoms for menopause until her stomach became swollen. Diagnosed with ...

Researchers develop targeted polymersomes loaded with methotrexate for the treatment of gestational choriocarcinoma, ...

UCR scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers ...

Nearly two months after Randy Moss underwent surgery following his cancer diagnosis, the ESPN commentator made an appearance virtually at the 2025 NFL Honors to present an award.

One especially frightening type of cancer that is extremely difficult to detect and seems to show up more often in Black ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...